Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) EBT Margin: 2016-2018

Historic EBT Margin for ENDRA Life Sciences (NDRA) over the last 2 years, with Mar 2018 value amounting to -45,761.31%.

  • ENDRA Life Sciences' EBT Margin was N/A to -45,761.31% in Q1 2018 from the same period last year, while for Mar 2018 it was -2,085.17%, marking a year-over-year change of. This contributed to the annual value of -10,607.97% for FY2024, which is 842326.00% down from last year.
  • Per ENDRA Life Sciences' latest filing, its EBT Margin stood at -45,761.31% for Q1 2018, which was down 36.61% from -33,498.39% recorded in Q4 2017.
  • In the past 5 years, ENDRA Life Sciences' EBT Margin registered a high of 368,239.39% during Q2 2016, and its lowest value of -45,761.31% during Q1 2018.
  • Its 3-year average for EBT Margin is 40,901.91%, with a median of -316.69% in 2017.
  • Data for ENDRA Life Sciences' EBT Margin shows a maximum YoY tumbled of 37,071,774bps (in 2017) over the last 5 years.
  • Quarterly analysis of 3 years shows ENDRA Life Sciences' EBT Margin stood at -133.61% in 2016, then crashed by 3,336,478bps to -33,498.39% in 2017, then reached -45,761.31% in 2018.
  • Its EBT Margin was -45,761.31% in Q1 2018, compared to -33,498.39% in Q4 2017 and -316.69% in Q3 2017.